Xiamen High-tech Investment
Overview
Xiamen High-tech Investment is a state-owned venture capital firm based in Xiamen, China, that focuses on early and mid-stage investments in hard-tech sectors including new materials, advanced manufacturing, semiconductor intelligent sensing, biomedicine, and new energy.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Asia Regenerative Medicine | Jun 2023 | VC Round | Co-investor |
| Shuocheng Technology | Jan 2019 | Pre Seed | Co-investor |
| Jiangsu Zhenyi Medical Technology Co., Ltd. | Aug 2024 | Series B Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Xiamen High-tech Investment based?
Xiamen High-tech Investment is headquartered in Xiamen, China.
When was Xiamen High-tech Investment founded?
Xiamen High-tech Investment was founded in 2013.
How many portfolio companies does Xiamen High-tech Investment have?
Xiamen High-tech Investment has 4 portfolio companies in Caplight's dataset.
What are some companies in Xiamen High-tech Investment's portfolio?
Portfolio companies visible on Caplight include Asia Regenerative Medicine, Shuocheng Technology, Jiangsu Zhenyi Medical Technology Co., Ltd..
What was Xiamen High-tech Investment's most recent investment shown here?
Xiamen High-tech Investment's most recent investment in this portfolio sample was in Jiangsu Zhenyi Medical Technology Co., Ltd. in 2024.
What sectors does Xiamen High-tech Investment focus on?
Xiamen High-tech Investment focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, AI, Data & Cloud Infrastructure.
What company stages does Xiamen High-tech Investment focus on?
Stage focus information for Xiamen High-tech Investment is not publicly available.
What is Xiamen High-tech Investment's AUM?
Xiamen High-tech Investment's assets under management are estimated between $276.0M and $276.0M.